Patents by Inventor Aude Violette

Aude Violette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hybrid oligomers, their preparation process and pharmaceutical compositions containing them
    Patent number: 8138145
    Abstract: The present invention relates to compositions and methods for producing therapeutic oligomeric compounds. In one aspect the invention relates to methods for administering the oligomeric compounds for the treatment and prevention of disease, for example, a fungal infection, bacterial infection, or cancer, in a mammal. In particular, the invention relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the invention may optionally be administered with at least one of a pharmaceutically acceptable excipient, pharmacologically active agent or a combination thereof.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: March 20, 2012
    Assignees: Centre National de la Recherche Scientifique (SNRS), ImmuPharma France SA
    Inventors: Aude Violette, Jean-Paul Briand, Robert H. Zimmer, Gilles Guichard
  • HYBRID OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    Publication number: 20100298206
    Abstract: The present invention relates to compositions and methods for producing therapeutic oligomeric compounds. In one aspect the invention relates to methods for administering the oligomeric compounds for the treatment and prevention of disease, for example, a fungal infection, bacterial infection, or cancer, in a mammal. In particular, the invention relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the invention may optionally be administered with at least one of a pharmaceutically acceptable excipient, pharmacologically active agent or a combination thereof.
    Type: Application
    Filed: February 18, 2010
    Publication date: November 25, 2010
    Applicants: Centre National de la Recherche Scientifique (CNRS), I.B.M.C., ImmuPharma France SA, Technopole
    Inventors: Aude Violette, Jean-Paul Briand, Robert H. Zimmer, Gilles Guichard
  • Hybrid oligomers, their preparation process and pharmaceutical compositions containing them
    Patent number: 7691807
    Abstract: The present invention relates to compositions and methods for producing therapeutic oligomeric compounds. In one aspect the invention relates to methods for administering the oligomeric compounds for the treatment and prevention of disease, for example, a fungal infection, bacterial infection, or cancer, in a mammal. In particular, the invention relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the invention may optionally be administered with at least one of a pharmaceutically acceptable excipient, pharmacologically active agent or a combination thereof.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: April 6, 2010
    Assignees: Centre National de la Recherche Scientifique (CNRS), ImmuPharma France SA
    Inventors: Aude Violette, Jean-Paul Briand, Robert Zimmer, Gilles Guichard
  • New hybrid oligomers, their preparation process and pharmaceutical compositions containing them
    Publication number: 20060211625
    Abstract: The present invention relates to compositions and methods for producing therapeutic oligomeric compounds. In one aspect the invention relates to methods for administering the oligomeric compounds for the treatment and prevention of disease, for example, a fungal infection, bacterial infection, or cancer, in a mammal. In particular, the invention relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the invention may optionally be administered with at least one of a pharmaceutically acceptable excipient, pharmacologically active agent or a combination thereof.
    Type: Application
    Filed: March 17, 2006
    Publication date: September 21, 2006
    Inventors: Aude Violette, Jean-Paul Briand, Robert Zimmer, Gilles Guichard